NCT06766279 Investigating the Efficacy of OMT to Recover Olfactory Perception After COVID-19
| NCT ID | NCT06766279 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Burrell College of Health Sciences |
| Condition | Anosmia |
| Study Type | INTERVENTIONAL |
| Enrollment | 32 participants |
| Start Date | 2024-08-29 |
| Primary Completion | 2025-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 32 participants in total. It began in 2024-08-29 with a primary completion date of 2025-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
One of the most widespread symptoms of COVID-19 is loss of the sense of smell. There are very few treatments for helping individuals recover their sense of smell. Osteopathic manipulative treatment (OMT) may be a useful tool in helping people recover their smell perception. In this study the investigators test whether OMT can be used to help individuals recover their sense of smell if they lost it during COVID-19.
Eligibility Criteria
Inclusion Criteria: * Positive COVID-19 test or diagnoses * Self-reported deficiency in sense of smell Exclusion Criteria: * Age under 18 years * Pregnancy * Any findings on the osteopathic screening/evaluation that would hinder the effectiveness or increase the risk associated with OA decompression * Any medication that interferes with the sense of smell (intranasal zinc, intranasal antihistamines, intranasal corticosteroids) * Allergic rhinitis * Use of oral corticosteroids or antihistamines.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06766279 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Anosmia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06766279 currently recruiting?
Yes, NCT06766279 is actively recruiting participants. Contact the research team at teiting@burrell.edu for enrollment information.
Where is the NCT06766279 trial being conducted?
This trial is being conducted at Las Cruces, United States.
Who is sponsoring the NCT06766279 clinical trial?
NCT06766279 is sponsored by Burrell College of Health Sciences. The trial plans to enroll 32 participants.